SH3PXD2A and non-small cell lung carcinoma: Moreover, previous research has demonstrated that SH3PXD2A antisense RNA 1 (SH3PXD2A-AS1) promotes the progression of various types of tumors [10–12], and was reported to be highly expressed in NSCLC and, hence, poor overall survival [2].